PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
04-Sep-2025 My Compounding Pharmacy: Revolutionizing Thyroid Treatment Through Personalized Medication Solutions ACCESS Newswire
04-Sep-2025 Outcomes' Vision Integrating the Pharmacy Industry Draws High Interest at National Wholesaler Summits and NACDS Total Store Expo Businesswire
04-Sep-2025 Former Deputy Chief Administrative Patent Judge Jackie Wright Bonilla Joins Sterne Kessler Businesswire
04-Sep-2025 Avel eCare and Alliant Purchasing Bring Virtual Care Solutions to the TORCH Fall Conference in Austin, TX ACCESS Newswire
04-Sep-2025 ProductLife Group Expands to Deliver Localized Expertise & Enhanced Client Support in Japan ProductLife Group
04-Sep-2025 Ginkgo Datapoints and Apheris Launch Antibody Developability Consortium; Ginkgo to Run AbDev AI Competition Ginkgo Datapoints
04-Sep-2025 Professor Brian Cox presents new science podcast BBC
04-Sep-2025 Pistoia Alliance unveils agentic AI initiative and seeks industry funding to drive safe adoption Pistoia Alliance
04-Sep-2025 AC Immune Sharpens Pipeline Focus with Operational Efficiencies Extending Cash Runway AC Immune
04-Sep-2025 TNF Pharmaceuticals Announces Closing of $7 Million Private Placement Businesswire
04-Sep-2025 Breakthrough Glioblastoma Treatments Move Closer to Patients as Medicines Discovery Catapult and King’s College London Secure Brain Tumour Charity Funding King’s College London
04-Sep-2025 Onco3R Therapeutics Announces Approval of First Clinical Trial Application for Novel SIK3 inhibitor O3R-5671 in Autoimmune Diseases Onco3R Therapeutics
04-Sep-2025 Asahi Kasei Microdevices Launches Camera less Integrated Sensing Modules for Detection of Falls, Vital Signs, Posture, and Position Asahi Kasei Microdevices
04-Sep-2025 PulseSight Therapeutics Provides New Insights into the Role of Iron and Transferrin in AMD, Supporting its PST-611 Vectorized Therapy for Dry AMD/Geographic Atrophy at EURETINA 2025 PulseSight Therapeutics
04-Sep-2025 Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis Sanofi
04-Sep-2025 Kuros Biosciences announces changes in the Board of Directors Kuros Biosciences
04-Sep-2025 Brainomix Stroke AI Software Hailed as ῾Revolutionary,’ Helping More Patients Fully Recover Brainomix
04-Sep-2025 ClearPoint Neuro Announces FDA Clearance Expanding Compatibility of the ClearPoint Prism Neuro Laser Therapy System with 1.5T MRI Scanners ACCESS Newswire
04-Sep-2025 NuCana to Present Data on NUC-7738’s Synergy with PD-1 Inhibitors at the ESMO Congress 2025 NuCana
04-Sep-2025 Health Economics Study on Ondine’s Steriwave® Selected for Oral Presentation at ICPIC 2025 in Geneva Ondine